Natalizumab in the treatment of Crohn’s disease

References

• AdelmanBSandrockAPanzaraMA2005Natalizumab and progressive multifocal leukoencephalopathyN Engl J Med353432315947083
   PubMed Web of Science ®Google Scholar
• AlonRKassnerPDCarrMW1995The integrins VLA-4 supports tethering and rolling in flow on VCAM-1J Cell Biol1281243537534768
   PubMed Web of Science ®Google Scholar
• BergerJRKoralnikIJ2005Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequencesN Engl J Med353414615947082
   PubMed Web of Science ®Google Scholar
• BerlinCBargatzeRFCampbellJJ1995Alpha4 integrins mediate lymphocyte attachment and rolling under physiologic flowCell80413227532110
   PubMed Web of Science ®Google Scholar
• BinionDGWestGAVolkEE1998Acquired increase in luokocyte binding by intestinal microvascular endothelium in inflammatory bowel diseaseLancet352174269848350
   PubMed Web of Science ®Google Scholar
• BrennanDCAghaIBohlDL2005Incidence of BK with tracolimus versus cyclosporine and impact of preemptive immunosuppression reductionAm J Transplant55829415707414
   PubMed Web of Science ®Google Scholar
• ButcherECPickerLJ1996Lymphocyte homing and homeostasisScience2726098600538
   PubMed Web of Science ®Google Scholar
• CasiniBBorgheseLDel NonnoF2005Presence and incidence of DNA sequences of human polyomavirus BKV and JCV in colorectal tumor tissueAnticancer Res2510798515868949
   PubMed Web of Science ®Google Scholar
• Elan Pharma (Europe) Ltd1997A phase I double-blind, placebo-controlled, ascending single intravenous dose, safety, tolerability, pharmacokinetic, immunogenicity and potency study in healthy male volunteers. Athena report nr. AN100226–101.
   Google Scholar
• FiocchiC1998Inflammatory bowel disease:etiology and pathogenesisGastroenterology1151822059649475
   PubMed Web of Science ®Google Scholar
• GoshSGoldinEGordonFH2003Natalizumab for active Crohn’s diseaseN Eng J Med3482432
   PubMed Web of Science ®Google Scholar
• GordonFHClementWYLHamiltonMI2001A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn’s diseaseGastroenterology1212687411487536
   PubMed Web of Science ®Google Scholar
• GordonFHHamiltonMIDonoghueS2002A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha4 integrinAliment Pharmacol Ther1669970511929387
   PubMed Web of Science ®Google Scholar
• HesterbergPEWinsor-HinesDBriskinMJ1996Rapid resolution of chroic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7Gastroenterology1111373808898653
   PubMed Web of Science ®Google Scholar
• HynesRO2002Integrins:bidirectional, allosteric signalling machinesCell1106738712297042
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMastersBKTylerKL2005Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosisN Engl J Med3533697415947079
   PubMed Web of Science ®Google Scholar
• KubesPNiuXFSmithCW1995A novel beta 1-dependent adhesion pathway on neutrophils:a mechanism invoked by dihydrocytochalasin B or endothelial transmigrationFASEB J91103117544310
   PubMed Web of Science ®Google Scholar
• Langer-GouldAAtlasSWGreenAJ2005Progressive multifocal leukoencephalopathy in a patient treated with natalizumabN Engl J Med3533758115947078
   PubMed Web of Science ®Google Scholar
• MacDonaldJKMcDonaldJWD2007Natalizumab for induction of remission in Crohn’s diseaseCochrane Database of Systematic Reviews2007Issue 1
   Web of Science ®Google Scholar
• MillerDHKhanOASherentaWA2003A controlled trial of natalizumab for relapsing multiple sclerosisN Engl J Med348152312510038
   PubMed Web of Science ®Google Scholar
• ModiglianiRMaryJYSimonJF1990Clinical biological and endoscopical picture of attacks of Crohn’s disease:evolution on prednisolone. Groupe d’etude therapeutique des affections inflammatoires digestivesGastroenterology9881182179031
   PubMed Web of Science ®Google Scholar
• NakamuraKHondaKMizutaniT2006Novel strategies for the treatment of inflammatory bowel disease:selective inhibition of cytokines and adhesion moleculesWorld J Gastroenterol1246283516937430
   PubMed Web of Science ®Google Scholar
• NivYGoelABolandCR2005JC virus and colorectal cancer :a possible trigger in the chromosomal instability pathwaysCurr Opin Gastroenterol2185915687890
   PubMed Web of Science ®Google Scholar
• OldenburgBHommesD2007Biological therapies in inflammatory bowel disease:top-down or bottom-up?Curr Opin Gastroenterol233959917545775
   PubMed Web of Science ®Google Scholar
• PicarellaDHurbutPRottmanJ1997Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhighCD4+ T-cellsJ immunol15820991069036954
   PubMed Web of Science ®Google Scholar
• PodolskyDKLobbRKingN1993Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibosyJ Clin Invest92372807686922
   PubMed Web of Science ®Google Scholar
• PodolskyDK2005Selective adhesion-molecule therapy and inflammatory bowel disease-a tale of Janus?N Engl J Med3531965816267329
   PubMed Web of Science ®Google Scholar
• SandbornWJColombelJFEnnsR2005Natalizumab induction and maintenance therapy for Crohn’s diseaseN Engl J Med35319122516267322
   PubMed Web of Science ®Google Scholar
• SorianoASalasASalasA2000VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in miceLab Invest8015415111045571
   PubMed Web of Science ®Google Scholar
• SpringerTA1994Traffic signals for lymphocyte recirculation and leukocyte emigration:the multistep systemCell76301147507411
   PubMed Web of Science ®Google Scholar
• StephensLESutherlandAEKlimanskayaIV1995Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethalityGenes Dev91883957544312
   PubMed Web of Science ®Google Scholar
• TarganSRFeaganBGFedorakRN2007Ntalizumab for the treatment of active Crohn’s disease:results of the ENCORE trialGastroenterology13216728317484865
   PubMed Web of Science ®Google Scholar
• Van AsscheGVan RanstMSciotR2005Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s diseaseN Engl J Med353362815947080
   PubMed Web of Science ®Google Scholar
• Von AndrianUHMackayCR2000T-cell function and migration:two sides of the same coinN Engl J Med34310203411018170
   PubMed Web of Science ®Google Scholar
• YednockTACannonCFritsLC1992Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4beta1 integrinNature3566361538783
   PubMed Web of Science ®Google Scholar
• YousryTAHabilMMajotEO2006Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathyN Engl J Med3549243316510746
   PubMed Web of Science ®Google Scholar